Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Free full text

Full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Review

Research Support, N.I.H., Extramural

Clinical Trial

Comparative Study

Research Support, N.I.H., Intramural

Research Support, U.S. Gov't, P.H.S.

Observational Study

Publication Year

From

Quick links

Individual year

2024

2022

2021

2020

2018

2016

2014

2012

2001

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Receptors, KIR""[mesh_terms]

16 Results

Searching titles within these results

Unconventional Peptide Presentation by Classical MHC Class I and Implications for T and NK Cell Activation.

Dirk M Zajonc

International journal of molecular sciences 2021;21(20):7561

Free Full Text

Abstract

Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes.

Michela Falco, Raffaella Meazza, Claudia Alicata, Paolo Canevali, Aura Muntasell, Cristina Bottino, Lorenzo Moretta, Daniela Pende, Miguel Lopez-Botet

HLA 2022;100(2):107-118

Free Full Text

Abstract

Co-evolution of NK receptors and HLA ligands in humans is driven by reproduction.

Ashley Moffett, Francesco Colucci

Immunological reviews 2016;267(1):283-97

Full Text

Abstract

HIV-1 evades a Gag mutation that abrogates killer cell immunoglobulin-like receptor binding and disinhibits natural killer cells in infected individuals with KIR2DL2+/HLA-C*03: 04+ genotype.

Maja C Ziegler, Kewreshini Naidoo, Anais Chapel, Sindiswa Nkotwana, Jaclyn Mann, Zenele Mncube, Nasreen Ismael, Philip Goulder, Thumbi Ndung'u, Marcus Altfeld, Christina F Thobakgale

AIDS (London, England) 2021;35(1):151-154

Free Full Text

Abstract

KIR specificity and avidity of standard and unusual C1, C2, Bw4, Bw6 and A3/11 amino acid motifs at entire HLA:KIR interface between NK and target cells, the functional and evolutionary classification of HLA class I molecules.

Slawomir Gwozdowicz, Klaudia Nestorowicz, Elzbieta Graczyk-Pol, Urszula Szlendak, Marta Rogatko-Koros, Renata Mika-Witkowska, Daria Pawliczak, Marta Zubala, Agnieszka Malinowska, Agnieszka Witkowska, Jacek Nowak

International journal of immunogenetics 2020;46(4):217-231

Full Text

Abstract

Centromeric AA motif in KIR as an optimal surrogate marker for precision definition of alloimmune reproductive failure.

Nabil Subhi-Issa, Miguel Fernández-Arquero, Silvia Sánchez-Ramón, Raquel Gil Laborda, Edgard Rodríguez de Frías, Elena Carrillo de Albornoz, Elena Meliá, Marcos Órdenes, Victoria Verdú, Juan Vidal, Esther Suárez, Isabel Santillán, Daniel Ordóñez, David Pintado-Vera, Victoria González Villafáñez, Ángel Lorenzo, Manuel Fariñas, Mario Rodríguez-Paíno, María Núñez Beltrán, Áurea García Segovia, Ainhoa Del Olmo, Fernando Martín Cañadas, Rosa Daurelio, Alfonso de la Fuente, José Manuel González Casbas, Vega Cabezuelo, Francisco Ros Berruezo, Miguel Ángel Moreno Hidalgo, Silvia Iniesta, Beatriz Bueno, Álvaro Martínez Acera, Alexandra Izquierdo, José Luis Vicario

Scientific reports 2024;14(1):3354

Free Full Text

Abstract

Influence of the immunogenetic KIR and HLA systems on long-term renal transplant outcome.

Gaetano La Manna, Serena Corsini, Sandra Iannelli, Maria Laura Cappuccilli, Giorgia Comai, Mario Iorio, Paola Todeschini, Elisa Carretta, Maria Piera Scolari, Andrea Bontadini, Segio Stefoni

Annals of transplantation 2014;18():611-21

Free Full Text

Abstract

KIR/HLA combination associated with the risk of complications in celiac disease.

Laura Caggiari, Giuseppe Toffoli, Valli De Re, Nicoletta Orzes, Michele Spina, Mariangela De Zorzi, Stefania Maiero, Renato Cannizzaro, Vincenzo Canzonieri

The International journal of biological markers 2012;26(4):221-8

Free Full Text

Abstract

Identification of a KIR antisense lncRNA expressed by progenitor cells.

P W Wright, A Huehn, F Cichocki, H Li, N Sharma, H Dang, T R Lenvik, P Woll, D Kaufman, J S Miller, S K Anderson

Genes and immunity 2014;14(7):427-33

Free Full Text

Abstract

Peptide-specific engagement of the activating NK cell receptor KIR2DS1.

Anaïs Chapel, Wilfredo F Garcia-Beltran, Angelique Hölzemer, Maja Ziegler, Sebastian Lunemann, Gloria Martrus, Marcus Altfeld

Scientific reports 2018;7(1):2414

Free Full Text

Abstract

KIR/HLA interactions negatively affect rituximab- but not GA101 (obinutuzumab)-induced antibody-dependent cellular cytotoxicity.

Grzegorz Terszowski, Christian Klein, Martin Stern

Journal of immunology (Baltimore, Md. : 1950) 2014;192(12):5618-24

Full Text

Abstract

High Metabolic Function and Resilience of NKG2A-Educated NK Cells.

Andrew J Highton, Björn-Philipp Diercks, Franziska Möckl, Gloria Martrus, Jürgen Sauter, Alexander H Schmidt, Madeleine J Bunders, Christian Körner, Andreas H Guse, Marcus Altfeld

Frontiers in immunology 2021;11():559576

Free Full Text

Abstract

Notch signaling at later stages of NK cell development enhances KIR expression and functional maturation.

Martin Felices, Dave E M Ankarlo, Todd R Lenvik, Heather H Nelson, Bruce R Blazar, Michael R Verneris, Jeffrey S Miller

Journal of immunology (Baltimore, Md. : 1950) 2014;193(7):3344-54

Free Full Text

Abstract

The multiple roles of major histocompatibility complex class-I-like molecules in mucosal immune function.

R S Blumberg, Y van de Wal, S Claypool, N Corazza, B Dickinson, E Nieuwenhuis, R Pitman, G Spiekermann, X Zhu, S Colgan, W I Lencer

Acta odontologica Scandinavica 2001;59(3):139-44

Free Full Text

Abstract

Interaction between the human NK receptors and their ligands.

M Valés-Gómez, H Reyburn, J Strominger

Critical reviews in immunology 2001;20(3):223-44

Full Text

Abstract

Results: 1 – 15 / 16

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Receptors, KIR""[mesh_terms]

Unconventional Peptide Presentation by Classical MHC Class I and Implications for T and NK Cell Activation.

Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes.

Co-evolution of NK receptors and HLA ligands in humans is driven by reproduction.

HIV-1 evades a Gag mutation that abrogates killer cell immunoglobulin-like receptor binding and disinhibits natural killer cells in infected individuals with KIR2DL2+/HLA-C*03: 04+ genotype.

KIR specificity and avidity of standard and unusual C1, C2, Bw4, Bw6 and A3/11 amino acid motifs at entire HLA:KIR interface between NK and target cells, the functional and evolutionary classification of HLA class I molecules.

Centromeric AA motif in KIR as an optimal surrogate marker for precision definition of alloimmune reproductive failure.

Influence of the immunogenetic KIR and HLA systems on long-term renal transplant outcome.

KIR/HLA combination associated with the risk of complications in celiac disease.

Identification of a KIR antisense lncRNA expressed by progenitor cells.

Peptide-specific engagement of the activating NK cell receptor KIR2DS1.

KIR/HLA interactions negatively affect rituximab- but not GA101 (obinutuzumab)-induced antibody-dependent cellular cytotoxicity.

High Metabolic Function and Resilience of NKG2A-Educated NK Cells.

Notch signaling at later stages of NK cell development enhances KIR expression and functional maturation.

The multiple roles of major histocompatibility complex class-I-like molecules in mucosal immune function.

Interaction between the human NK receptors and their ligands.

Results for
""Receptors, KIR""[mesh_terms]